an interim analysis of the current eortc studies in advanced testicular cancer indicates that ( a ) for low volume metastatic disease the addition of bleomycin ( b ) to etoposide ( e ) and cisplatinum ( p ) may not be necessary , and ( b ) for high volume metastatic disease the alternating schedule of pvb/bep is not superior to treatment with bep .
C0005740
bleomycin
C0072634
pvb